share_log

港市速睇 | 三大指数收涨,芯片股、医药股全天强势,华虹半导体飙涨超13%

A quick look at the Hong Kong market | The three major indices closed higher, chip stocks and pharmaceutical stocks were strong throughout the day, and Huahong Semiconductor soared more than 13%

富途資訊 ·  Aug 5, 2022 16:21

Futu Information on August 5 | the three major indexes of Hong Kong stocks closed higher, the Hang Seng Index rose 0.14%, the Hang Seng Index rose 0.79%, and the State-owned Enterprises Index rose 0.33%.

As of the close, Hong Kong stocks rose 1237, fell 625, and closed flat at 1033.

The specific industry performance is shown below:

Plate aspectMost of the large technology stocks fellBABA fell more than 2%, Tencent and NetEase, Inc fell more than 1%, Kuaishou Technology, Meituan and JD.com followed suit.

Semiconductor plate continues to pull upHua Hong Semiconductor rose by more than 13%, Semiconductor Manufacturing International Corporation by 7% and Pacific by more than 6%.

Pharmaceutical stocks strengthenBeiGene, Ltd. rose nearly 12%, INNOVENT BIO nearly 9%, Genscript Biotech Corporation nearly 7%, Kang Bio-B up more than 8%, Rongchang Bio-B followed.

Apple Inc concept stock continues to riseSunny Optical Technology rose by more than 5%, Gao Wei by nearly 3%, AAC Technologies Holdings Inc. by more than 2% and BYD Electronic by more than 1%.

Shipping stocks roseOrient Overseas rose by more than 7%, COSCO Shipping Holdings by nearly 3%, Pacific Shipping and SITC International Holdings followed.

Most non-ferrous metal stocks roseZhaojin Mining rose nearly 5%, Aluminum Corporation Of China Ltd and Zijin Mining Group rose nearly 3%, and Ganfeng Lithium rose slightly.

Property management stock reboundedJinke service and Xuhui Yongsheng service rose by nearly 8%, Country Garden Services Holdings by nearly 4%, and WTO service by more than 1%.

Individual stocks$Hua Hong Semiconductor (01347.HK) $It rose by more than 13%.Hua Hong Semiconductor said that price increases are still under way for customers, which will be reflected in Q2 and the second half of the year. At the same time, production capacity expansion is also continuing, hoping to reach 95000 pieces by 2023. Huahong also said that it has not encountered any noise from the consumer electronics industry.Morgan Stanley's latest research report gives Hua Hong Semiconductor a rating of increasing his holdings, with a target price of HK $41.

Time Electric (03898.HK) $is up more than 12%. Time Electric said that IGBT has been widely used in power transmission and distribution, rail transit, new energy vehicles, wind power generation, photovoltaic power generation, high-voltage frequency converter and other fields. Minsheng Securities issued a research report on time Electric, "2022 half-year performance Forecast Review: Q2 performance is in line with expectations, new energy development is fierce", the research newspaper gave time Electric a "buy" rating.

$INNOVENT BIO (01801.HK) $rose nearly 9%. The company announced that on August 4, 2022, the group entered into a multi-project strategic cooperation and licensing agreement with Sanofi Group to cooperate in the clinical development and commercialization of two high-potential antineoplastic drugs in China, including exploring a series of clinical studies in conjunction with the company's PD-1 inhibitor Dabeshu (Xindilizumab injection).

$Semiconductor Manufacturing International Corporation (00981.HK) $Up more than 7%.On the news side, the geopolitical tension strengthens the expectation of domestic substitution, with many countries scrambling to strengthen industry status and increase subsidies, the market is also looking forward to China's chip industry ushering in independent control. Goldman Sachs reported that the bank expects Semiconductor Manufacturing International Corporation's profit margins to decline in the coming quarters, given the weak demand for smartphones and consumer electronics in the coming quarters. The bank maintains a "neutral" rating with a target price of HK $20.2.

$BeiGene, Ltd. (06160.HK) $Up nearly 12%.BeiGene, Ltd. released interim results, the company achieved revenue of 648.2 million US dollars in the first half of this year. Nomura released a research report saying it gave BeiGene, Ltd. a "buy" rating with a target price of HK $167.48

Hong Kong stock exchange fund

As for Hong Kong Stock Connect, there was a net inflow of HK $438 million from Hong Kong Stock Connect (southbound) today.

Today's turnover of Hong Kong shares TOP20

Message surface

Hong Kong Exchanges and Clearing: the total market value of the securities market at the end of July was HK $35.9 trillion.

Hong Kong Exchanges and Clearing: the total market value of the securities market was HK $35.9 trillion at the end of July 2022, down 8 per cent from HK $39.1 trillion at the end of last month.

Ministry of Industry and Information Technology: the average price of battery-grade lithium carbonate rose 45.4% in the first half of the year compared with the same period last year.

The Ministry of Industry and Information Technology released the operation of the nickel-cobalt-lithium industry in the first half of 2022, according to the data of Beijing Antaike Information Co., Ltd., the average spot prices of electrolytic nickel, metal cobalt and battery-grade lithium carbonate in the first half of 2022 were 206000 yuan / ton, 514000 yuan / ton and 453000 yuan / ton, respectively, up 57%, 48.5% and 454% from the same period last year. In the second quarter, due to the impact of tighter global liquidity and sluggish downstream demand, prices of nickel, cobalt and battery-grade lithium carbonate fell 44.2%, 32.5% and 6.8% respectively from this year's highs on June 30.

China rare Earth Industry Association: the output of major rare earth functional materials maintained steady growth in the first half of the year.

According to the China rare Earth Industry Association, the output of major rare earth functional materials maintained steady growth in the first half of the year. In terms of rare earth magnetic materials, the output of sintered NdFeB blank was 116000 tons, an increase of 15% over the same period last year; the output of bonded NdFeB was 4490 tons, an increase of 2% over the same period last year; and the output of samarium cobalt magnets was 1490 tons, an increase of 14.6% over the same period last year. In terms of rare earth catalytic materials, the output of petroleum catalytic cracking catalysts was 109000 tons, down 4.4 percent from the same period last year, and the output of vehicle exhaust purifiers was 9.75 million liters, an increase of 36.4 percent over the same period last year. For rare earth luminescent materials, the output of LED phosphors was 289.5 tons, down 14.9 percent from the same period last year; the output of tricolor phosphors was 360tons, down 13.9 percent from the same period last year; and the output of long afterglow phosphors was 120.5 tons, down 5.9 percent from the same period last year. The output of rare earth hydrogen storage materials was 4398 tons, down 13.4% from the same period last year. The output of rare earth polishing materials was 16000 tons, down 8.4% from the same period last year.

General Administration of Market Supervision: strictly investigate and bid up coal prices and make clear the red line of the law

According to a news release from the State Administration of Market Supervision and Administration, recently, the General Administration of Market Supervision has organized three investigation teams to conduct investigations in Shanxi, Inner Mongolia and Shaanxi to further strengthen the supervision of thermal coal prices, clarify the legal red line, and standardize the order of thermal coal prices. This investigation highlights three key points. First, highlight the key issues, in view of the previous suspected bid-up prices, price collusion and other clues to carry out key investigations. The second is to highlight the key links and firmly grasp the key to the "pit price" of coal production enterprises. The third is to highlight the key areas, focusing on the investigation of coal enterprises in the three main power coal producing areas. Through the investigation, it is preliminarily identified that 18 coal enterprises are suspected of driving up coal prices, and 3 trading centers are suspected of not implementing government pricing.

Institutional viewpoint

Guoxin Securities: it is not weak in the off-season in July, and is optimistic that the volume and profit of the automobile industry will increase in the second half of the year.

Guoxin Securities pointed out that the off-season in July is not weak, and it is optimistic that the volume and profit of the automobile industry will increase in the second half of the year. On the supply side, the automobile industry chain in the Yangtze River Delta has been restored one after another. since June 1, Shanghai has abolished the examination and approval system for the resumption of work and production of enterprises and established a service mechanism for commissioners of key foreign-funded enterprises to return to work and production. An one-time subsidy of 10000 yuan will be given to individual consumers who replace pure electric vehicles. On the demand side, the recent frequent local subsidy stimulus policies, superimposed 60 billion purchase tax reduction catalysis, car sales in the second half of the year is expected to improve significantly. The rising trend of raw material prices has been gradually curbed, car volume and profits have increased, or become the core strong plate in the second half of the year.

Galaxy Securities: the replenishment of lithium salt by the lithium industry chain as a whole may lead to a new round of rise in lithium prices.

Galaxy Securities pointed out that under the stimulation of downstream terminal demand for new energy vehicles scheduled in August or continued month-on-month growth, the operating rate and scheduling plans of battery factories and material plants in the lithium industry chain rebounded rapidly, and downstream demand increased lithium salt consumption significantly, and lithium prices began to rebound gradually in July. The cathode materials and battery manufacturers who interrupted normal production and raw material procurement due to the previous epidemic are currently maintaining low inventory of lithium salt raw materials, and lithium salt factory inventory is also low. in the case of downstream demand recovery and a large number of new production capacity of lithium iron phosphate put into production at the end of 2022 and early 2023, the replenishment of lithium salt by the lithium industry chain as a whole may lead to a new round of rise in lithium prices.

Daiwa: maintain$BABA-SW (09988.HK) $Buy rating with a target price of HK $150

According to a research report released by Daiwa, maintaining the BABA-SW "buy" rating, customer management income (CMR) of the core Chinese business business is expected to rise 1 per cent year-on-year in the second quarter to the end of September, with a target price of HK $150. The bank said that BABA's core business sectors in the first fiscal quarter ended at the end of June were better than expected, and although the cloud business revenue was slightly lower, it believed that the market underestimated the rising profit trend. The company will strictly control costs in the next few quarters, coupled with being undervalued by investors, the share price is expected to benefit from the recovery of mainland consumption in the second half of the year. In addition, dual major listing permits in Hong Kong, good news from Ant Group and buybacks will be the main share price catalysts for the follow-up.

Nomura: maintain$Wuxi Biologics (02269.HK) $Buy rating, target price rises to HK $97.78

Maintaining Wuxi Biologics's "buy" rating, Nomura expects revenue and net profit to grow 62 per cent and 37 per cent year-on-year in the first half of this year, according to a research report released by Nomura. At the same time, the revenue forecast for fiscal year 2022Unix 23 will be increased by 3% by 4%, and the profit forecast by 10% by 6%, to reflect stronger growth momentum, with the target price rising from HK $95.75 to HK $97.78. According to the report, the strategic cooperation between the company and AstraZeneca PLC (AZN.US) on the localized production of COVID-19 's preventive drug "Enshi" is another cooperation after COVID-19 's vaccine cooperation, reflecting the deeper trust between the two sides.

Edit / ruby

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment